Consumer Group Wants Public to Share Profits From Federally Funded Stem Cell and Medical Research
Posted on: Monday, 9 March 2009, 12:33 CDT
Lauds Lifting of Ban and Calls on President Obama to Follow Policies Established by California Stem Cell Agency
In a letter to President Obama, the nonpartisan nonprofit Consumer Watchdog said policies developed by the California Institute for Regenerative Medicine (CIRM), which runs the state's
"Your action will undoubtedly spur new gains in this vital area of medical research," wrote
Most of the federal funding for biomedical research is funneled through the National Institutes of Health. Basic scientific research is usually done at universities and non-profit research institutions, most of it with federal funds. Under the Bayh-Dole Act discoveries that are made at these institutions can be patented by them. They then license the patents to industry. The royalties go only to the universities and research institutions. Nothing is returned to the taxpaying public who funded the research.
"Under Bayh-Dole, the public pays twice for medical discoveries," said Simpson, "First we fund the research; then we are faced with high drug prices protected by the monopoly that the patent guarantees."
Consumer Watchdog said federal policies for public funding of scientific research should incorporate these four principles:
--When a discovery has been funded by the public, the public should share in any profits.
--If the public has paid for key discoveries, then government policies should guarantee affordable access to cures and treatments resulting from those discoveries.
--If the government has funded an invention, but the patent holder does not commercialize it, the government should be able to license the invention to someone who will.
--The results of all federally funded research should be available to all U.S. researchers for further research without a licensing fee. Once taxpayers pay to develop a technology, all researchers should have free access to it for further non-commercial research.
"When venture capitalists provide money to companies they require clearly spelled out conditions and expectations," said Simpson. "There is no reason it should be any different when taxpayers put their hard-earned dollars on the line to fund research."
The California Institute for Regenerative Medicine (CIRM) was created by the voters of
Key elements of its Intellectual Property Policy regulations are provisions for a payback to the state. For example, if there is revenue to a research institution as the result of publicly funded research, 25 percent goes back to the state's general fund. The IP policy also has provisions to help ensure affordability and access by uninsured people to cures and treatments that were developed with public money.
Read Consumer Watchdog's letter here: http://www.consumerwatchdog.org/resources/ltrobamastemcell030909.pdf
Consumer Watchdog, formerly The Foundation for Taxpayer and Consumer Rights, is a nonpartisan, nonprofit organization with offices in
SOURCE Consumer Watchdog
Source: PR Newswire
Related Articles
- Research Provides Documentation That Tumor 'Stem-Like Cells' Exist In Benign Tumors
- Governor Rendell Says PA Still Seeks Public Input on Federal Broadband Stimulus Funds
- New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
- Pennsylvania Governor Rendell Announces Statewide Public Meetings on Federal Broadband Stimulus Funds
- Federal Coordinating Council on Comparative Effectiveness Research to Hold Public Listening Session in Washington, DC
- Consumer Watchdog to U.S. Senate: Don't Leave Consumers Out of Health Reform Debate, Public Opposes Mandatory Purchases of Private Insurance & Supports Opening Medicare to Everyone
- Consumer Watchdog Calls on HMO Regulator to Disclose Communications With Insurance Companies Regarding Autism Coverage Denials
- Pancreatic Cancer Action Network Launches Unprecedented Initiative to Secure Federal and Private Funding for Pancreatic Cancer Research: Raise the Cure
- Chemicon International, Inc. Enters into a License to Commercialize Research Products Utilizing Human Embryonic Stem Cell Technology From Wisconsin Alumni Research Foundation (WARF)
- Ethical Guidelines Suggested for Research that Would Put Human Stem Cells in Primates
User Comments (0)

RSS Feeds